Johnson & Johnson

JNJ-N

NYSE:JNJ

149.17
0.97 (0.65%)
Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
More at Wikipedia

Analysis and Opinions about JNJ-N

Signal
Opinion
Expert
TOP PICK
TOP PICK
July 7, 2004
Pays a little over 2% dividend. A multitude of products. Terrific track record of making money. A safe place to be in uncertain times.
Show full opinionHide full opinion
Pays a little over 2% dividend. A multitude of products. Terrific track record of making money. A safe place to be in uncertain times.
TOP PICK
TOP PICK
May 28, 2004
With the feds tightening and profit growths slowing, the market is going ahead for higher quality stocks. A well-run company and is not expensive.
Show full opinionHide full opinion
With the feds tightening and profit growths slowing, the market is going ahead for higher quality stocks. A well-run company and is not expensive.
BUY
BUY
May 17, 2004
Likes the longer-term outlook for pharmaceuticals. Historically, they have performed relatively well when interest rates are going up.
Show full opinionHide full opinion
Likes the longer-term outlook for pharmaceuticals. Historically, they have performed relatively well when interest rates are going up.
BUY
BUY
May 14, 2004
Health-care sector is the best sector to be in. Can't think of anything better than this stock. Wide range of products.
Show full opinionHide full opinion
Health-care sector is the best sector to be in. Can't think of anything better than this stock. Wide range of products.
DON'T BUY
DON'T BUY
April 20, 2004
Big pharmas have a problem of being too big and gets more leverage through Boston Scientific.
Show full opinionHide full opinion
Big pharmas have a problem of being too big and gets more leverage through Boston Scientific.
TOP PICK
TOP PICK
April 16, 2004
Very high-quality stock.
Show full opinionHide full opinion
Very high-quality stock.
BUY
BUY
April 13, 2004
A great blue-chip company. A wonderful line of consumer products, some good pharmaceuticals and, making money on their coated stent. This stock will not have fast growth.
Show full opinionHide full opinion
A great blue-chip company. A wonderful line of consumer products, some good pharmaceuticals and, making money on their coated stent. This stock will not have fast growth.
TOP PICK
TOP PICK
March 26, 2004
One of his 2 favourite areas is health care because of the demographics. You can buy at a discount to the market.
Show full opinionHide full opinion
One of his 2 favourite areas is health care because of the demographics. You can buy at a discount to the market.
BUY
BUY
March 17, 2004
There is competition in the stent market. The whole health-care sector is a bit of a puzzle. Has been executing very well, but money just doesn't seem to want to flow into health-care.
Show full opinionHide full opinion
There is competition in the stent market. The whole health-care sector is a bit of a puzzle. Has been executing very well, but money just doesn't seem to want to flow into health-care.
TOP PICK
TOP PICK
March 5, 2004
One of a handful of AAA Company's out there. Great dividend history. Reasonable P/E valuation. Hasn't participated in the strong market over the course of the last year or so.
Show full opinionHide full opinion
One of a handful of AAA Company's out there. Great dividend history. Reasonable P/E valuation. Hasn't participated in the strong market over the course of the last year or so.
TOP PICK
TOP PICK
March 5, 2004
A non cyclical stock. Pays a dividend yield in the healthcare sector.
Show full opinionHide full opinion
A non cyclical stock. Pays a dividend yield in the healthcare sector.
HOLD
HOLD
December 23, 2003
They've been groeing their market share by 20% throughout the last 4 years. Trading at evaluation standards that are fantastic, looks attractive for long-term hold, Drug companies are undervalued., could see some good gains.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 23, 2003
They've been groeing their market share by 20% throughout the last 4 years. Trading at evaluation standards that are fantastic, looks attractive for long-term hold, Drug companies are undervalued., could see some good gains.
BUY
BUY
December 12, 2003
In the long term, it's a great diversified play in the healthcare sector.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 12, 2003
In the long term, it's a great diversified play in the healthcare sector.
DON'T BUY
DON'T BUY
December 5, 2003
Has been stuck around $50 mark. Took a big jump when they first produced a stent but they now have competition, which is taking quite a bit of market share. Could see it go a bit lower.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 5, 2003
Has been stuck around $50 mark. Took a big jump when they first produced a stent but they now have competition, which is taking quite a bit of market share. Could see it go a bit lower.
TOP PICK
TOP PICK
October 27, 2003
A contrarian play. Has performed very well from a financial perspective. Growth prospect is a very positive. Very good long-term value.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
October 27, 2003
A contrarian play. Has performed very well from a financial perspective. Growth prospect is a very positive. Very good long-term value.
Showing 391 to 405 of 438 entries